Instituto Rosenbusch S.A. (BCBA:ROSE)

Market Cap	7.03B +71.2%
Revenue (ttm)	6.40B -41.2%
Net Income	-4.60B
EPS	-107.95
Shares Out	42.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,405
Average Volume	111,509
Open	163.00
Previous Close	167.00
Day's Range	162.00 - 166.50
52-Week Range	83.50 - 450.00
Beta	0.03
RSI	46.15
Earnings Date	Apr 1, 2026

About Instituto Rosenbusch

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1917
• Country: Argentina
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ROSE

Financial Performance

In 2025, Instituto Rosenbusch's revenue was 6.40 billion, a decrease of -41.17% compared to the previous year's 10.89 billion. Losses were -4.60 billion, 146.6% more than in 2024.